Mylan Facility in West Virginia Draws Warning Letter

Drug Industry Daily
A A
The FDA came down on another Mylan facility with a warning letter — this time in Morgantown, West Virginia — for CGMP violations similar to those previously observed at other company plants.

To View This Article:

Login

Subscribe To Drug Industry Daily